NDAINJECTIONINJECTABLE
Approved
Mar 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NUROMAX (doxacurium chloride) is an injectable neuromuscular blocking agent approved in 1991 for use during anesthesia and surgery. It acts as a competitive antagonist at the neuromuscular junction to facilitate intubation and provide muscle relaxation during surgical procedures. The drug is administered intravenously to patients requiring anesthesia-induced paralysis.
LOE Approaching
As LOE approaches, the NUROMAX brand team is likely consolidating and focusing on retention strategies rather than aggressive expansion, signaling potential restructuring or transition roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on NUROMAX offers limited growth opportunity given its LOE-approaching status and mature market position, with career focus shifting toward operational excellence, cost management, and potential portfolio transition. Roles on this product may serve as stable, shorter-term assignments rather than long-term career anchors, particularly suitable for professionals seeking hands-on experience in specialty pharmaceutical operations or contract management before transitioning to growth-stage products.
Brand Manager
Worked on NUROMAX at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.